AUTONOMIX MEDICAL, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AUTONOMIX MEDICAL, INC. (AMIX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 512.39 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 512.39K shares, a 441.64% increase year-over-year.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 94.60K shares, a 66.10% decline year-over-year.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 279.07K shares, a 96.28% decline year-over-year.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 7.50M shares.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 10.76M shares, a 443.13% increase from fiscal 2025.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.98M shares, a 1117.14% increase from fiscal 2024.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 162.77K shares, a 97.52% decline from fiscal 2023.
- AUTONOMIX MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.57M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 512.39K shares 10-Q · filed 2026-08-13 | ||||||||
| 2026-03-31 | 10.76M shares 10-K · filed 2026-05-27 | ||||||||
| 2025-12-31 | 10.76M shares 10-Q · filed 2026-02-11 | ||||||||
| 2025-09-30 | 1.76M shares 10-Q · filed 2025-11-12 | ||||||||
| 2025-06-30 | 94.60K shares 10-Q · filed 2026-08-13 | ||||||||
| 2025-06-03 | 1.99M shares 10-Q · filed 2025-08-13 | ||||||||
| 2025-03-31 | 1.98M shares 10-K · filed 2026-05-27 | ||||||||
| 2024-12-31 | 2.01M shares 10-Q · filed 2026-02-11 | ||||||||
| 2024-09-30 | 279.07K shares 10-Q · filed 2025-11-12 | 362.27K shares 10-Q · filed 2024-11-08 | |||||||
| 2024-06-30 | 279.07K shares 10-Q · filed 2025-08-13 | 10.84M shares 10-Q · filed 2024-08-13 | |||||||
| 2024-06-03 | 279.07K shares 10-Q · filed 2025-08-13 | ||||||||
| 2024-03-31 | 162.77K shares 10-K · filed 2025-05-29 | 8.91M shares 10-K · filed 2024-05-31 | |||||||
| 2023-12-31 | 243.49K shares 10-Q · filed 2025-02-13 | 10.72M shares 10-Q · filed 2024-02-13 | |||||||
| 2023-09-30 | 510.93K shares 10-Q · filed 2024-11-08 | ||||||||
| 2023-06-30 | 7.50M shares 10-Q · filed 2024-08-13 | ||||||||
| 2023-03-31 | 6.57M shares 10-K · filed 2024-05-31 | ||||||||
| 2022-12-31 | 6.57M shares 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |